For in vitro diagnostic use. Others Elecsys HSV-1 IgG IVD Elecsys® HSV-1 IgG CPS_000484 08948844190 HSV-1 IgG Elecsys cobas e 100 V2 Elecsys HSV-1 IgG 07613336170649 Reagents, kits 100 tests cobas e 411/601/602 true 08948844160 HSV-1 IgG Elecsys cobas e 100 V2 Elecsys HSV-1 IgG 07613336170663 Reagents, kits 100 tests cobas e 411/601/602 true 05572185190 HSV-1 IgG Elecsys cobas e 100 Elecsys HSV-1 IgG 04015630927463 Reagents, kits 100 tests cobas e 411/601/602 true 05572185160 HSV-1 IgG Elecsys cobas e 100 Elecsys HSV-1 IgG 04015630939046 Reagents, kits 100 tests cobas e 411/601/602 true 07027494190 HSV-1 IgG Elecsys E2G 100 Elecsys HSV-1 IgG 04015630940431 Reagents, kits 100 tests cobas e 402/801 true 08948852190 HSV-1 IgG Elecsys E2G 100 V2 Elecsys HSV-1 IgG 07613336170656 Reagents, kits 100 tests cobas e 402/801 true 08948844500 Elecsys HSV-1 IgG en 1 FF00000004F27E0E FF00000004F27E0E 08948844190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoassay for the in vitro qualitative determination of IgG class antibodies to HSV‑1 in human serum and plasma. The test is intended for use as an aid in the assessment of immune status and as an aid in the diagnosis of HSV infection.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 08948844501 Elecsys HSV-1 IgG en 1 FF00000005DF380E FF00000005DF380E 08948844160 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of IgG class antibodies to HSV‑1 in human serum and lithium‑heparin plasma, K2‑EDTA plasma, and K3‑EDTA plasma. The test is intended for sexually active individuals and expectant mothers as an aid in the presumptive diagnosis of HSV‑1 infection. The test results may not determine the state of active lesions or associated disease manifestations, particularly for primary infection. The predictive value of positive and negative results depends on the population's prevalence and the pretest likelihood of HSV‑1.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers.This test is not FDA‑cleared for screening blood or plasma donors.The performance of this assay has not been established for use in a pediatric population, neonates, immunocompromised patients, or for use at point‑of‑care facilities. en ms_05572185190 Elecsys HSV-1 IgG en 8 FF000000044CE10E FF00000000345F0E 05572185190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoassay for the in vitro qualitative determination of IgG class antibodies to HSV‑1 in human serum and plasma. The test is intended for use as an aid in the assessment of immune status and as an aid in the diagnosis of HSV infection.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en ms_05572185160_USA Elecsys HSV-1 IgG en 5 FF0000000274330E FF0000000050930E 05572185160 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of IgG class antibodies to HSV‑1 in human serum and lithium‑hepain plasma, K2‑EDTA plasma, and K3‑EDTA plasma. The test is intended for sexually active individuals and expectant mothers as an aid in the presumptive diagnosis of HSV‑1 infection. The predicative value of positive and negative results depends on the population's prevalence and the pretest likelihood of HSV‑1.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers.This test is not FDA‑cleared for screening blood or plasma donors.The performance of this assay has not been established for use in a pediatric population, neonates, immunocompromised patients, or for use at point‑of‑care facilities. en 07027494500 Elecsys HSV-1 IgG en 1 FF00000001B24C0E FF00000001B24C0E 07027494190 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoassay for the in vitro qualitative determination of IgG class antibodies to HSV‑1 in human serum and plasma. The test is intended for use as an aid in the assessment of immune status and as an aid in the diagnosis of HSV infection.The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e 801 immunoassay analyzer. en 07027494500 Elecsys HSV-1 IgG en 4 FF000000049AED0E FF0000000453650E 07027494190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoassay for the in vitro qualitative determination of IgG class antibodies to HSV‑1 in human serum and plasma. The test is intended for use as an aid in the assessment of immune status and as an aid in the diagnosis of HSV infection.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07027494501 Elecsys HSV-1 IgG en 2 FF00000005D1850E FF00000001F1560E 07027494190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of IgG class antibodies to HSV‑1 in human serum and lithium‑heparin plasma, K2‑EDTA plasma, and K3‑EDTA plasma. The test is intended for sexually active individuals and expectant mothers as an aid in the presumptive diagnosis of HSV‑1 infection. The predicative value of positive and negative results depends on the population's prevalence and the pretest likelihood of HSV‑1.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers.This test is not FDA‑cleared for screening blood or plasma donors.The performance of this assay has not been established for use in a pediatric population, neonates, immunocompromised patients, or for use at point‑of‑care facilities. en 08948852501 Elecsys HSV-1 IgG en 1 FF00000005E0630E FF00000005E0620E 08948852190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of IgG class antibodies to HSV‑1 in human serum and lithium‑heparin plasma, K2‑EDTA plasma, and K3‑EDTA plasma. The test is intended for sexually active individuals and expectant mothers as an aid in the presumptive diagnosis of HSV‑1 infection. The test results may not determine the state of active lesions or associated disease manifestations, particularly for primary infection. The predicative value of positive and negative results depends on the population's prevalence and the pretest likelihood of HSV‑1.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers.This test is not FDA‑cleared for screening blood or plasma donors.The performance of this assay has not been established for use in a pediatric population, neonates, immunocompromised patients, or for use at point‑of‑care facilities. en 08948852500 Elecsys HSV-1 IgG en 2 FF00000005ED540E FF0000000518C10E 08948852190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoassay for the in vitro qualitative determination of IgG class antibodies to HSV‑1 in human serum and plasma. The test is intended for use as an aid in the assessment of immune status and as an aid in the diagnosis of HSV infection.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en